Bariatric embolization for nonalcoholic steatohepatitis
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests a procedure called bariatric embolization, which uses tiny particles to block blood flow to part of the stomach, to help you lose weight and reduce liver inflammation from NASH. It might be an option if you have NASH and have not been able to lose weight with diet and exercise alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 22 years or older.
- Have a diagnosis of NASH confirmed by a liver biopsy within the past year.
- Have a BMI greater than 35.
- Have raised liver enzyme levels (ALT or AST).
- Not have any other cause of liver disease or significant alcohol use.
- Be able to safely undergo the procedure and follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether weight-loss (bariatric) surgery helps people with fatty liver disease, including “NASH,” and related liver scarring. If you have obesity and a confirmed liver fat diagnosis (and for NASH, biopsy-proven NASH with some fibrosis), the study may follow your outcomes after surgery.
This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.
This trial compares a less invasive heart/artery-based bariatric treatment (bariatric arterial embolization) with standard weight-loss surgery to see how they affect metabolism and type 2 diabetes. You might be considered if you have obesity with type 2 diabetes and have not had prior bariatric surgery.
This study looks at how the body processes energy in people with fatty liver disease who are having weight-loss surgery. It may help doctors understand the disease better and could lead to better treatments.
This study tests if a procedure called endoscopic sleeve gastroplasty helps people with obesity and a liver condition called MASH lose weight and improve their liver health. It might be an option if you have both obesity and MASH and haven't had weight-loss surgery before.
This study tests a stomach procedure (endoscopy) to help people with obesity lose weight or control health problems linked to weight. You may be considered if other weight-loss efforts have not worked and surgery is not the best option for you.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.